Ksienski D - Search Results

1

Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.

Ksienski D, Gupta S, Truong PT, Bone J, Chan A, Alex D, Hart J, Pollock P, Patterson T, Clarkson M, Dissanayake D, Sonke E, Lesperance M. Ksienski D, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):2951-2961. doi: 10.1007/s00432-022-04181-0. Epub 2022 Jul 14. J Cancer Res Clin Oncol. 2023. PMID: 35834010 Free PMC article.

2

Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.

Ksienski D, Wai ES, Croteau N, Fiorino L, Brooks E, Poonja Z, Fenton D, Geller G, Glick D, Lesperance M. Ksienski D, et al. Clin Lung Cancer. 2019 Jan;20(1):e97-e106. doi: 10.1016/j.cllc.2018.09.005. Epub 2018 Sep 22. Clin Lung Cancer. 2019. PMID: 30337270

3

Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice.

Ksienski D, Wai ES, Croteau N, Freeman AT, Chan A, Fiorino L, Brooks EG, Poonja Z, Fenton D, Geller G, Irons S, Lesperance M. Ksienski D, et al. Lung Cancer. 2019 Jul;133:110-116. doi: 10.1016/j.lungcan.2019.05.005. Epub 2019 May 18. Lung Cancer. 2019. PMID: 31200816

4

Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab.

Ksienski D, Wai ES, Croteau NS, Freeman AT, Chan A, Fiorino L, Poonja Z, Fenton D, Patterson T, Irons S, Lesperance M. Ksienski D, et al. J Geriatr Oncol. 2020 Jun;11(5):807-813. doi: 10.1016/j.jgo.2020.01.006. Epub 2020 Jan 11. J Geriatr Oncol. 2020. PMID: 31937494

5

Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab.

Freeman AT, Lesperance M, Wai ES, Croteau NS, Fiorino L, Geller G, Brooks EG, Poonja Z, Fenton D, Irons S, Ksienski D. Freeman AT, et al. Among authors: ksienski d. Curr Oncol. 2020 Apr;27(2):76-82. doi: 10.3747/co.27.5495. Epub 2020 May 1. Curr Oncol. 2020. PMID: 32489249 Free PMC article.

6

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab.

Ksienski D, Wai ES, Alex D, Croteau NS, Freeman AT, Chan A, Patterson T, Clarkson M, Fiorino L, Poonja Z, Fenton D, Irons S, Lesperance M. Ksienski D, et al. Transl Lung Cancer Res. 2021 Jan;10(1):355-367. doi: 10.21037/tlcr-20-541. Transl Lung Cancer Res. 2021. PMID: 33569318 Free PMC article.

7

Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort.

Ksienski D, Truong PT, Wai ES, Croteau NS, Chan A, Patterson T, Clarkson M, Hackett S, Irons S, Lesperance M. Ksienski D, et al. Clin Oncol (R Coll Radiol). 2021 Dec;33(12):e561-e569. doi: 10.1016/j.clon.2021.06.009. Epub 2021 Jul 3. Clin Oncol (R Coll Radiol). 2021. PMID: 34226113

8

Ksienski D, Truong PT, Croteau NS, Chan A, Sonke E, Patterson T, Clarkson M, Hackett S, Lesperance M. Ksienski D, et al. J Geriatr Oncol. 2022 Mar;13(2):220-227. doi: 10.1016/j.jgo.2021.10.002. Epub 2021 Oct 13. J Geriatr Oncol. 2022. PMID: 34654653

9

Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday Practice.

Ksienski D, Truong PT, Croteau NS, Chan A, Sonke E, Patterson T, Clarkson M, Lesperance M. Ksienski D, et al. Cureus. 2021 Nov 23;13(11):e19835. doi: 10.7759/cureus.19835. eCollection 2021 Nov. Cureus. 2021. PMID: 34963849 Free PMC article.

10

First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic.

Lakkunarajah S, Truong PT, Bone JN, Hughesman C, Yip S, Alex D, Hart J, Pollock P, Egli S, Clarkson M, Lesperance M, Ksienski D. Lakkunarajah S, et al. Among authors: ksienski d. Transl Lung Cancer Res. 2023 Jul 31;12(7):1454-1465. doi: 10.21037/tlcr-23-81. Epub 2023 Jul 21. Transl Lung Cancer Res. 2023. PMID: 37577326 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters